These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 30716203

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Therapeutic strategies for autoimmune hepatitis.
    Manns MP, Strassburg CP.
    Dig Dis; 2011; 29(4):411-5. PubMed ID: 21894012
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.
    Efe C, Hagström H, Ytting H, Bhanji RA, Müller NF, Wang Q, Purnak T, Muratori L, Werner M, Marschall HU, Muratori P, Gunşar F, Klintman D, Parés A, Heurgué-Berlot A, Schiano TD, Cengiz M, May-Sien Tana M, Ma X, Montano-Loza AJ, Berg T, Verma S, Larsen FS, Ozaslan E, Heneghan MA, Yoshida EM, Wahlin S.
    Clin Gastroenterol Hepatol; 2017 Dec; 15(12):1950-1956.e1. PubMed ID: 28603052
    [Abstract] [Full Text] [Related]

  • 7. Assessing the efficacy and safety of mycophenolate mofetil versus azathioprine in patients with autoimmune hepatitis (CAMARO trial): study protocol for a randomised controlled trial.
    Snijders RJALM, Stoelinga AEC, Gevers TJG, Pape S, Biewenga M, Verdonk RC, de Jonge HJM, Vrolijk JM, Bakker SF, Vanwolleghem T, de Boer YS, Pronk MAMCB, Beuers UHW, van der Meer AJ, van Gerven NMF, Sijtsma MGM, Verwer BJ, Gisbertz IAM, Bartelink M, van den Brand FF, Sebib Korkmaz K, van den Berg AP, Guichelaar MMJ, Soufidi K, Levens AD, van Hoek B, Drenth JPH, Dutch Autoimmune Hepatitis Working Group.
    Trials; 2022 Dec 13; 23(1):1012. PubMed ID: 36514163
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.
    Richardson PD, James PD, Ryder SD.
    J Hepatol; 2000 Sep 13; 33(3):371-5. PubMed ID: 11019991
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials.
    Lamers MM, van Oijen MG, Pronk M, Drenth JP.
    J Hepatol; 2010 Jul 13; 53(1):191-8. PubMed ID: 20400196
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
    Inductivo-Yu I, Adams A, Gish RG, Wakil A, Bzowej NH, Frederick RT, Bonacini M.
    Clin Gastroenterol Hepatol; 2007 Jul 13; 5(7):799-802. PubMed ID: 17509945
    [Abstract] [Full Text] [Related]

  • 13. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis.
    Hlivko JT, Shiffman ML, Stravitz RT, Luketic VA, Sanyal AJ, Fuchs M, Sterling RK.
    Clin Gastroenterol Hepatol; 2008 Sep 13; 6(9):1036-40. PubMed ID: 18586559
    [Abstract] [Full Text] [Related]

  • 14. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy.
    Fallatah HI, Akbar HO.
    Expert Rev Gastroenterol Hepatol; 2011 Aug 13; 5(4):517-22. PubMed ID: 21780898
    [Abstract] [Full Text] [Related]

  • 15. Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
    Zizzo AN, Valentino PL, Shah PS, Kamath BM.
    J Pediatr Gastroenterol Nutr; 2017 Jul 13; 65(1):6-15. PubMed ID: 28644343
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?
    Abdollahi M, Ekrami NK, Ghojazadeh M, Boezen HM, Somi M, Alizadeh BZ.
    World J Gastroenterol; 2020 Oct 14; 26(38):5896-5910. PubMed ID: 33132643
    [Abstract] [Full Text] [Related]

  • 17. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis.
    Park SW, Um SH, Lee HA, Kim SH, Sim Y, Yim SY, Seo YS, Ryu HS.
    Clin Mol Hepatol; 2016 Jun 14; 22(2):281-5. PubMed ID: 27246353
    [Abstract] [Full Text] [Related]

  • 18. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis.
    Hanouneh M, Ritchie MM, Ascha M, Ascha MS, Chedid A, Sanguankeo A, Zein NN, Hanouneh IA.
    Scand J Gastroenterol; 2019 Jan 14; 54(1):76-80. PubMed ID: 30650311
    [Abstract] [Full Text] [Related]

  • 19. Mycophenolate mofetil for autoimmune hepatitis: a single practice experience.
    Wolf DC, Bojito L, Facciuto M, Lebovics E.
    Dig Dis Sci; 2009 Nov 14; 54(11):2519-22. PubMed ID: 19082888
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of Autoimmune Hepatitis].
    Kim JK.
    Korean J Gastroenterol; 2023 Feb 25; 81(2):72-85. PubMed ID: 36824035
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.